Literature DB >> 24385674

Focal venous hypertension as a pathophysiologic mechanism for tissue hypertrophy, port-wine stains, the Sturge-Weber syndrome, and related disorders: proof of concept with novel hypothesis for underlying etiological cause (an American Ophthalmological Society thesis).

Cameron F Parsa1.   

Abstract

PURPOSE: To provide an in-depth re-examination of assumed causes of tissue hypertrophy, port-wine stains, and the Sturge-Weber, Cobb, Klippel-Trénaunay, and related syndromes to support an alternative unifying pathophysiologic mechanism of venous dysplasia producing focal venous hypertension with attendant tissue responses; to provide proof of concept with new patient data; to propose a novel etiological hypothesis for the venous dysplasia in these syndromes and find supportive evidence.
METHODS: Data from 20 patients with port-wine stains and corneal pachymetry readings was collected prospectively by the author in an institutional referral-based practice. The literature was searched using MEDLINE, and articles and textbooks were obtained from the bibliographies of these publications.
RESULTS: Newly obtained dermatologic, corneal pachymetry, fundus ophthalmoscopic, ocular and orbital venous Doppler ultrasonography, and magnetic resonance imaging findings in patients with the Sturge-Weber syndrome or isolated port-wine stains, along with published data, reveal diffusely thickened tissues and neural atrophy in all areas associated with venous congestion.
CONCLUSIONS: Contrary to traditional understanding, signs and symptoms in the Sturge-Weber and related syndromes, including both congenital and acquired port-wine stains, are shown to arise from effects of localized primary venous dysplasia or acquired venous obstruction rather than neural dysfunction, differentiating these syndromes from actual phacomatoses. Effects of focal venous hypertension are transmitted to nearby areas via compensatory collateral venous channels in the above conditions, as in the Parkes Weber syndrome. A novel underlying etiology-prenatal venous thrombo-occlusion-is proposed to be responsible for the absence of veins with persistence and enlargement of collateral circulatory pathways with data in the literature backing this offshoot hypothesis. The mechanism for isolated pathologic tissue hypertrophy in these syndromes clarifies physiologic mechanisms for exercise-induced muscle hypertrophy to occur via venous compression and increased capillary transudation.

Entities:  

Mesh:

Year:  2013        PMID: 24385674      PMCID: PMC3871829     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  235 in total

Review 1.  Sturge-Weber syndrome: a review.

Authors:  Kristin A Thomas-Sohl; Dale F Vaslow; Bernard L Maria
Journal:  Pediatr Neurol       Date:  2004-05       Impact factor: 3.372

2.  The value of the brain scan and cerebral arteriogram in the Sturge-Weber syndrome.

Authors:  B McCaughan; R A Ouvrier; K De Silva; A McLaughlin
Journal:  Proc Aust Assoc Neurol       Date:  1975

3.  A hypothesis of cerebral venous system regulation based on a study of the junction between the cortical bridging veins and the superior sagittal sinus. Laboratory investigation.

Authors:  Jean-Rodolphe Vignes; Arnaud Dagain; Jean Guérin; Dominique Liguoro
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

4.  Sturge-Weber-Dimitri syndrome, cephalic form of neurocutaneous hemangiomatosis.

Authors:  B W LICHTENSTEIN
Journal:  AMA Arch Neurol Psychiatry       Date:  1954-03

5.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

6.  The cutaneous manifestations of Sturge-Weber syndrome.

Authors:  M Uram; C Zubillaga
Journal:  J Clin Neuroophthalmol       Date:  1982-12

7.  Klippel-Trénaunay syndrome: spectrum and management.

Authors:  A G Jacob; D J Driscoll; W J Shaughnessy; A W Stanson; R P Clay; P Gloviczki
Journal:  Mayo Clin Proc       Date:  1998-01       Impact factor: 7.616

8.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.

Authors:  C Heller; R Schobess; K Kurnik; R Junker; G Günther; W Kreuz; U Nowak-Göttl
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

9.  The syndrome of facial nevi, anomalous cerebral venous return, and hydrocephalus.

Authors:  L S Orr; R H Osher; P J Savino
Journal:  Ann Neurol       Date:  1978-04       Impact factor: 10.422

10.  Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome.

Authors:  C B Yang; S F Freedman; J S Myers; E G Buckley; L W Herndon; R R Allingham
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

View more
  12 in total

Review 1.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

Review 2.  Pathophysiology, diagnosis, and management of glaucoma associated with Sturge-Weber syndrome.

Authors:  Usman Javaid; Muhammad Hassaan Ali; Samreen Jamal; Nadeem Hafeez Butt
Journal:  Int Ophthalmol       Date:  2017-01-07       Impact factor: 2.031

Review 3.  Imaging patterns of venous-related brain injury in children.

Authors:  Luke L Linscott; James L Leach; Blaise V Jones; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2017-11-17

4.  Osseous intramedullary signal alteration and enhancement in Sturge-Weber syndrome: an early diagnostic clue.

Authors:  Matthew T Whitehead; Gilbert Vezina
Journal:  Neuroradiology       Date:  2015-01-16       Impact factor: 2.804

5.  Ahmed valve implantation in childhood glaucoma associated with Sturge-Weber syndrome: our experience.

Authors:  Jaya Kaushik; Jitendra Kumar Singh Parihar; Vaibhav Kumar Jain; Vijay Mathur
Journal:  Eye (Lond)       Date:  2018-10-18       Impact factor: 3.775

Review 6.  An Update on the Ophthalmologic Features in the Phakomatoses.

Authors:  Solmaz Abdolrahimzadeh; Andrea Maria Plateroti; Santi Maria Recupero; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2016-07-17       Impact factor: 1.909

Review 7.  Ophthalmic Alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: An Independent Group of Conditions?

Authors:  Solmaz Abdolrahimzadeh; Vittorio Scavella; Lorenzo Felli; Filippo Cruciani; Maria Teresa Contestabile; Santi Maria Recupero
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

8.  Rat Model of Parkes Weber Syndrome.

Authors:  Krzysztof Bojakowski; Gabriela Janusz; Iwona Grabowska; Oliwia Zegrocka-Stendel; Agnieszka Surowiecka-Pastewka; Magdalena Kowalewska; Dorota Maciejko; Katarzyna Koziak
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

Review 9.  Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management.

Authors:  Flavio Mantelli; Alice Bruscolini; Maurizio La Cava; Solmaz Abdolrahimzadeh; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-05-13

10.  Correction of Facial Deformity in Sturge-Weber Syndrome.

Authors:  Kazuaki Yamaguchi; Daniel Lonic; Chit Chen; Lun-Jou Lo
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.